Encouraging results have been obtained for drugs by Bristol-Myers Squibb Co. and Merck & Co. for treating Hodgkin’s lymphoma. The drug acts by boosting the immune system by blocking a pathway called PD-1 and fight the cancer cells which managed to evade the natural defenses of the body. Another Merck’s drug, Keytruda has been given […]